Comments
Aurobindo Pharma Ltd’s consolidated net profit increased 33 per cent at Rs 605.64 crore in the second quarter ended September 30, 2016 compared to Rs 453.55 crore in the corresponding quarter of previous financial year.
The total revenue of the Hyderabad-based company has increased 12% at Rs 3775 cr as against Rs 3365 crore.
The board of the company has approved an interim divided of 125 per cent per equity share of Rs 1 for the year 2016-17.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.